Selling your equity used to be tough, but with EquityZen, getting cash for your private shares is simple — no mountains of paperwork.
Whether you’re an employee of a startup looking to diversify your portfolio or an angel investor seeking liquidity from an early investment, EquityZen can help you get the liquidity you deserve.
EquityZen helps you sell your Zymergen shares to fund life’s biggest expenses: a new home, student loans, an engagement ring or even your dream car.
Zymergen is a biotechnology company that, according to their website, “integrates automation, machine learning, and genomics to rapidly accelerate the pace of scientific advancement.” Their intent is to unlock new sources of molecular diversity which in turn improves the yield of their customers' fermentation processes.
Their material solutions have been used across the pharmaceutical, agriculture, electronics, and chemical industries. But Zymergen is secretive about its customers - naming them “Fortune 50” to “Fortune 500” companies - and their revenue figures, with their CEO stating only that their partners have sold $500 million worth of products made with Zymergen’s bugs in the last couple of years.
Zymergen’s primary competitor in the biotechnology and microorganism industry is Ginko Bioworks, a 9-year-old company that has raised nearly $430 million to date. In comparison, Zymergen has raised roughly $575 million since 2015.
Notably, a 2018 whitepaper published by Zymergen highlights multiple market opportunities and success stories they have had with their customers but also notes that they are continuing to develop their own products and search for long-term commercial partners.
Biotechnology and genetic engineering are constantly evolving industries that have traditionally required long lead-times and heavy R&D spending. Zymergen likes to highlight how they are different and how quickly their technology can positively impact customers, indicating their willingness to push the industry forward and into the future.
Create an account and take a quick survey about your holdings. This information is crucial to our process. From there, we will perform initial due diligence, begin a valuation analysis, and determine whether the company is a fit for our platform.
We will list the offering to gauge interest from our investor base and report back to you. This process typically takes two weeks, and the offering will be featured on our website and in our weekly investor newsletter during such time.
If there’s enough investor demand, we will work with the company to complete the transaction. Your sales proceeds will hit your account in 2-3 weeks from the completed transaction and voilà, your liquid!
Specific customer experiences are not representative of all customer experiences and are no guarantee of future returns or success.
“Through EquityZen, I got cash for my private stock, at both a better price and larger volume than the company itself offered through SecondMarket. The whole process was very straightforward and efficient.”
—Lucas, ex-employee, billion-dollar company
“It was great doing business with you guys. You are much better than your competitors who I was dealing with! 10 million times!”
—SS, shareholder in multi-billion-dollar company
If your net worth is tied up in employee equity, then join more than 20,000 shareholders who have accessed liquidity via our marketplace and diversify your net worth.
Buy a home, start a family or pay for your child’s tuition. You shouldn’t have to put your life on hold. Companies operate on a different timeline and are taking longer to go public.
Our platform guides you through the complex process of transferring equity ownership and keeps you updated on the progress of your sale. Execute and manage all your transfer documents easily on EquityZen.